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Aims The cardiac ryanodine receptor (RyR2), which mediates intracellular Ca2þ release to trigger cardiomyocyte con-
traction, participates in development of acquired and inherited arrhythmogenic cardiac disease. This study was un-
dertaken to characterize the network of inter- and intra-subunit interactions regulating the activity of the RyR2
homotetramer.
....................................................................................................................................................................................................
Methods
and results
We use mutational investigations combined with biochemical assays to identify the peptide sequence bridging the
b8 with b9 strand as the primary determinant mediating RyR2 N-terminus self-association. The negatively charged
side chains of two aspartate residues (D179 and D180) within the b8–b9 loop are crucial for the N-terminal inter-
subunit interaction. We also show that the RyR2 N-terminus domain interacts with the C-terminal channel pore re-
gion in a Ca2þ-independent manner. The b8–b9 loop is required for efficient RyR2 subunit oligomerization but it is
dispensable for N-terminus interaction with C-terminus. Deletion of the b8–b9 sequence produces unstable tetra-
meric channels with subdued intracellular Ca2þ mobilization implicating a role for this domain in channel opening.
The arrhythmia-linked R176Q mutation within the b8–b9 loop decreases N-terminus tetramerization but does not
affect RyR2 subunit tetramerization or the N-terminus interaction with C-terminus. RyR2R176Q is a characteristic
hypersensitive channel displaying enhanced intracellular Ca2þ mobilization suggesting an additional role for the b8–
b9 domain in channel closing.
....................................................................................................................................................................................................
Conclusion These results suggest that efficient N-terminus inter-subunit communication mediated by the b8–b9 loop may con-
stitute a primary regulatory mechanism for both RyR2 channel activation and suppression.
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1. Introduction
The ryanodine receptor (RyR), a homotetramer whose subunits each
consists of 5000 amino acids, mediates sarcoplasmic reticulum (SR)
Ca2þ release to enable excitation–contraction coupling.1 In mamma-
lian adult heart, RyR2 is activated by Ca2þ influx through L-type
voltage-gated channels acting as a Ca2þ signal amplifier to initiate sar-
comere contraction.2 Abnormal RyR2 gating perturbs cardiomyocyte
Ca2þ handling resulting in acquired and inherited arrhythmogenic
cardiac disease.3,4 The recent determination of the RyR1 and RyR2
structures at near-atomic resolution by electron cryomicroscopy has
been a major scientific breakthrough in the study of the Ca2þ release
channel.5–10 For the first time, it has been possible to visualize not
only secondary structural elements of the peptide backbone but also
the position of amino acid side chains for the majority (70%) of the
RyR1/2 molecular mass. Structural comparison of the channel’s open
and closed states reveals that RyR regulation is governed by extensive
inter- and intra-subunit interactions. Among them, N-terminal inter-
subunit interactions appear to be of paramount importance for the
gating of the channel, a phenomenon also indicated by X-ray crystal-
lography/computational docking11,12 and demonstrated by biochemi-
cal/functional observations.13–15
Here, we describe inter-domain contact sites and assess their role in
the regulation of the RyR2 channel. We propose that N-terminus
self-association is the gatekeeper of RyR2 channel activity, instrumental
in both the pore’s opening and closing mechanisms. Robust N-terminal
inter-subunit interactions maintain the wild-type channel closed,
whereas modest disruption of N-terminus tetramerization results in a
hypersensitive channel as seen with the pathogenic R176Q mutation.
Severe disruption of N-terminus tetramerization due to deletion of the
b8–b9 loop, which also leads to impaired RyR2 tetramers, results in
hyposensitive channels.
2. Methods
2.1 Materials
The human embryonic kidney (HEK) 293 cell line was obtained from
ATCCVR (CRL-1573), mammalian cell culture reagents and Fluo-3 AM
were obtained from Thermo Scientific, CHAPS from Merck, protease in-
hibitor cocktail (CompleteTM) from Roche, nProtein-A Sepharose from
GE Healthcare, electrophoresis equipment and reagents from Bio-Rad,
enhanced chemiluminescence detection kit from Thermo Scientific,
DNA restriction endonucleases from New England Biolabs, Pfu DNA
polymerase from Promega, side-directed mutagenesis kit (QuikChange II
XL) from Agilent Technologies, T7 Gene 6 Exonuclease from
Graphical Abstract
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Affymetrix, oligonucleotides, and all other reagents from Sigma unless
otherwise stated.
2.2 Plasmid construction
The plasmid encoding for wild-type RyR2 N-terminus (NT, residues 1–
906) tagged with the cMyc epitope at the N-terminus has been described
previously.15 The four-alanine substitution within the b13–b14 loop and
the small three-residue deletion within the b23–b24 loop (NTb13–b14/
4Ala and NTDb23–b24, respectively) were generated in NT using the side-
directed mutagenesis QuikChange II XL kit and the complementary pri-
mers listed in Supplementary material online, Table S1. Larger deletions
(within the b8–b9, b20–b21 and b30–b31 loops) were generated using
PCR amplification as described elsewhere.16 Briefly, primers were
designed to contain four consecutive phosphorothioate residues located
12 nucleotides from the 5’end, which enabled digestion with T7 Gene 6
Exonuclease, thereby converting the blunt ends of the PCR product into
12-nucleotide 3’-end overhangs. In addition, the six outermost nucleoti-
des of each primer were complementary to the six nucleotides of the re-
verse primer located immediately before the phosphorothioate
residues, which resulted in self-circularization of the PCR product fol-
lowing exonuclease digestion. PCR was carried out using the side-
directed mutagenesis kit, and the PCR product, firstly digested with DpnI
followed by digestion with T7 Gene 6 Exonuclease, was transformed
into bacteria to obtain plasmid DNA. Plasmid encoding for human
RyR2Db8–b9 was prepared by replacing a SpeI–BstEII 3.8 kb fragment
into the WT plasmid, whereas RyR2R176Q plasmid has previously been
described.17 An RyR2 C-terminal fragment (residues 3529–4967) was
generated by PCR amplification from full-length human RyR2 cDNA and
cloned into pCR3 (Thermo Scientific, Loughborough, UK) containing an
N-terminal HA epitope tag (HA-RyR2-CT). All plasmid constructs were
verified by direct DNA sequencing.
2.3 Chemical cross-linking
HEK293 cells were transiently transfected with plasmid DNA encoding
for RyR2 NT constructs using TurboFect (Thermo Scientific,
Loughborough, UK) according to the provider’s instructions. In 24 h
post-transfection, cells were homogenized on ice in homogenization
buffer [5 mM HEPES, 0.3 M sucrose, 10 mM dithiothreitol (DTT), pH
7.4] by 20 passages through a needle (0.6 mm  30 mm) and dispersing
the cell suspension through half volume of glass beads (425–600
microns, Sigma). Cell nuclei and glass beads were removed by centrifuga-
tion at 1500 g for 5 min at 4C. The supernatant obtained following a
subsequent centrifugation step (20000  g for 10 min at 4C) was
retained and protein concentration was measured using the bicincho-
ninic acid (BCA) colorimetric assay (Thermo Scientific, Loughborough,
UK). Cell homogenate (20lg) was incubated with glutaraldehyde
(0.0025% or 260lmol/L) for the following time-points: 0 min, 2 min,
5 min, 10 min, 15 min, 20 min, 30 min, and 1 h. The reaction was stopped
with the addition of hydrazine (2%) and SDS-PAGE loading buffer
(60 mM Tris, 2% SDS, 10% glycerol, 5 mM EDTA, 0.01% bromophenol
blue, pH 6.8). Samples were analysed by SDS-PAGE and immunoblotting
with AbcMyc (mouse 9E10, Santa Cruz Biotechnology; used at 1:1000 di-
lution). Tetramer to monomer ratio was determined by densitometry
using a GS-900 Scanner (Bio-Rad, Watford, Hertfordshire, UK) and
Image Lab software (Bio-Rad, Watford, Hertfordshire, UK). Tetramer
formation was calculated as follows: T = ODT/(ODT þ ODM)  100,
where ODT and ODM correspond to optical density obtained for tetra-
mer and monomer bands respectively. Statistical analysis was carried out
with GraphPad Prism software using Kruskal–Wallis test with Dunn’s
multiple comparison test.
2.4 Co-immunoprecipitation
HEK293 cells were transiently co-transfected with plasmid DNA for
HA-RyR2-CT (residues 3529–4967 tagged with HA epitope) together
with RyR2 NT constructs (residues 1–906 tagged with cMyc epitope) us-
ing TurboFect. In 24 h post-transfection cells were homogenized on ice
in buffer (20 mM Tris, 150 mM NaCl, pH 7.4) as described above. Cell
nuclei and glass beads were removed by centrifugation at 1500  g for
5 min at 4C and the supernatant was incubated overnight at 4C in the
presence of 0.5% CHAPS under rotary agitation. Following overnight
solubilization and centrifugation at 20 000  g for 10 min at 4C to re-
move the insoluble material, the supernatant was incubated at 4C for
6 h with protein A sepharose beads (GE Healthcare) and 2lg of AbHA
(rabbit ab9110, Abcam) under rotary agitation [2lg of normal, non-
immune rabbit IgG (Santa Cruz Biotechnology) was used as negative
control]. Beads were recovered at 1500  g for 2 min at 4C, washed
two times (10 min at 4C) with the IP buffer (20 mM Tris, 150 mM NaCl,
0.5% CHAPS, pH 7.4) and proteins were eluted with SDS-PAGE loading
buffer. A small amount (1/10th) of the IP samples was analysed by SDS-
PAGE and immunoblotting with AbHA (mouse 16B12, Biolegend; used at
1:1000 dilution) to assess HA-RyR2-CT expression and immunoprecipi-
tation. The rest (9/10th) of the IP samples was analysed by SDS-PAGE
and immunoblotting with AbcMyc (mouse 9E10, Santa Cruz
Biotechnology; used at 1:1000 dilution) to assess the amount of the co-
precipitated RyR2 NT construct. The amount of co-precipitated RyR2
NT proteins was determined by densitometry (using GS-900 Scanner
and Image Lab software), normalized against the amount of the input
protein in the lysate and specific binding was calculated by subtracting
the non-immune IgG IP signal from the anti-HA IP signal. Statistical analy-
sis was carried out using one-way analysis of variance with Bonferroni’s
multiple comparisons test.
2.5 Sucrose density gradient
centrifugation
HEK293 cells transiently transfected with full-length human RyR2 plas-
mid DNA using TurboFect were harvested after 24 h. Cells were resus-
pended (106 cells/mL) in hypo-osmotic homogenization buffer (20 mM
Tris, 1 mM EDTA, pH 7.4, supplemented with protease inhibitors) and
homogenized on ice by 20 passages through a needle (0.6 mm 
30 mm). Cell nuclei and unbroken cells were removed by centrifugation
at 1500 g for 5 min at 4C and the supernatant was subjected to cen-
trifugation at 100 000  g for 1 h at 4C in order to obtain the micro-
somal fraction. Protein content was measured using the BCA assay and
microsomes were solubilized for 1 h at 4C in high-salt buffer (1 M NaCl,
0.15 mM CaCl2, 0.1 mM EGTA, 25 mM PIPES, 0.6% CHAPS, 0.3% phos-
phatidylcholine, 2 mM DTT, pH 7.4, supplemented with protease inhibi-
tors) at a protein concentration of 2.5 mg/mL. The insoluble material
was removed by centrifugation at 16 000  g for 10 min at 4C and the
supernatant was layered onto a continuous (5–40%) sucrose density gra-
dient prepared in buffer (300 mM NaCl, 25 mM Tris, 50 mM HEPES,
0.3 mM EGTA, 0.1 mM CaCl2, 0.3% CHAPS, 0.15% phosphatidylcholine,
2 mM DTT, pH 7.4, supplemented with protease inhibitors). The gradi-
ent was spun at 100 000  g for 16 h at 4C, fractions were collected,
and sucrose concentration was measured using a refractometer. Protein
distribution was analysed by SDS-PAGE and immunoblotting with RyR2
Ab1093 (raised against human RyR2 residues 4454–4474; used at 1:500
A ryanodine receptor domain vital for Ca2þ release 3
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dilution) characterized previously.17–19 Densitometry analysis was per-
formed (using GS-900 Scanner and Image Lab software) and the amount
of RyR2 in each fraction was normalized against the amount of input pro-
tein in the microsomes.
2.6 [3H]ryanodine binding
[3H]ryanodine binding was performed on HEK293 microsomes express-
ing RyR2WT or RyR2Db8–b9 in the presence of 100lM CaCl2 and 10 mM
caffeine to promote maximum channel activation. 200lg of HEK293
microsomes were incubated at 37C for 2 h in the presence of 8 nM
[3H]ryanodine (Perkin-Elmer, Seer Green, Buckinghamshire, UK) in
binding buffer (25 mM PIPES, 1 M KCl, 2 mM DTT, pH 7.4). Samples
were vacuum filtered through glass-fiber filters (GF/F Whatman), incu-
bated overnight in scintillation liquid (Ultima Gold, Perkin Elmer), and ra-
dioactivity (dpm) was quantified using a scintillation counter (Tri-Carb
2100 TR, Packard BioScience). Specific binding was calculated from total
by subtracting non-specific binding (in the presence of 10lM non-
radiolabelled ryanodine) from three separate experiments each per-
formed in duplicate.
2.7 Calcium imaging
Single-cell Ca2þ imaging of HEK293 cells expressing RyR2 was adapted
from an assay developed by Chen et al.20 Cells (1 105) were seeded
on poly-lysine coated glass bottom dishes (MatTek, Bratislava, Slovakia)
and transiently transfected with plasmid DNA for full-length human
RyR2 using Effectene (Qiagen, Manchester, UK) according to the manu-
facturer’s instructions. After 48 h, cells were loaded with Fluo-3 AM
(10lM) for 1 h at 30C and immersed in buffer (120 mM NaCl, 25 mM
HEPES, 5.5 mM glucose, 4.8 mM KCl, 1.3 mM CaCl2, 1.2 mM KH2PO4,
1.2 mM MgCl2, pH 7.4) for imaging at 37C. RyR2-mediated spontaneous
Ca2þ release events were monitored using a laser scanning confocal mi-
croscope (Leica SP5) and LAS-AF software (Leica Microsystems, Milton
Keynes, UK) with the following parameters:20 magnification objective
lens, excitation at 488 nm and fluorescence emission detected at 500–
550 nm, 512  512 pixel resolution, 100 ms time interval and scanning
speed of 400 Hz. Cells were imaged for 3 min (5 min when thapsigargin
was applied) and acquired regions of interest representing global Ca2þ
environments (typically50 lm2) were selected. A broad range of para-
metric values was calculated from experimental traces by home devel-
oped MATLAB (MathWorks) based software. Parameters include
oscillatory amplitude, transient duration, frequency of events, caffeine re-
sponse (10 mM caffeine-induced Ca2þ transient typically taken as indica-
tion of Ca2þ store content), and response to (1lM) thapsigargin. The
store Ca2þ content was calculated as the integral of the experimental
time-series following administration of caffeine and thapsigargin. To ac-
count for the prolonged tail at the end of the measurement, an exponen-
tial decay function was fitted on each trace in order to evaluate the total
Ca2þ release from stores. Statistical analysis was performed using Mann–
Whitney test.
3. Results
3.1 Identification of the N-terminus
inter-subunit contact sites
We have previously found that the RyR2 N-terminus (NT, residues
1–906) displays robust self-association shown by yeast two-hybrid, co-
immunoprecipitation (co-IP), gel filtration, and chemical cross-linking
assays.13–15 Previous X-ray crystallography and computational docking
studies placed the four N-terminal domains immediately adjacent to
each other at the centre of full-length RyR111,12 enabling visualization of
putative contact sites. In particular, the peptide sequence connecting the
b8 with the b9 strand (b8–b9 loop) on one subunit is in close physical
proximity with the b23–b24 loop and possibly with the b13–b14 loop
(which was not resolved in the crystal structure) on the adjacent subunit.
Furthermore, the b20–b21 loop on one subunit may be within contact
distance with the b20–b21 loop of a neighbouring subunit. In order to
empirically test the involvement of these sequences in RyR2 N-terminus
tetramerization, we generated a number of discrete NT constructs with
targeted small internal deletions for use in cross-linking assays
(Supplementary material online, Table S2). To ensure that the overall
folding of the NT peptide is unaffected, deletion constructs did not in-
volve complete removal of all the amino acids within the targeted loop
but retained some residues sufficient to bridge the adjoining b sheets. In
the case of the short four-residue b13–b14 loop, removal of any of these
four amino acids could potentially alter the local conformation of the
surrounding b sheets and, therefore, a four-alanine substitution rather
than deletion was generated. NT deletion constructs were expressed in
HEK293 cells and reacted with glutaraldehyde, which creates stable brid-
ges between pre-existing protein complexes, and oligomer formation
was analysed by western blotting using AbcMyc (Figure 1A). Cross-linking
of NTDb8–b9 resulted in the appearance of the tetramer; however, its
abundance was extremely low relative to NTWT. Collective data (n>_ 6)
following densitometry analysis demonstrated that deletion of the b8–
b9 loop resulted in substantial reduction (by 79% at 60 min) of the tetra-
mer compared to WT (Figure 1B). NTb13–b14/4Ala, NTDb20–b21 and
NTDb31–b32, the latter serving as negative control, produced oligomers
to the same extent as NTWT, whereas deletion of the b23–b24 se-
quence resulted in reduced tetramer formation (by 39% at 60 min) that
did not reach statistical significance compared to WT. These findings sug-
gest a supporting role for the b23–b24 loop and identify the b8–b9 loop
as the primary structural determinant for RyR2 N-terminus self-
association.
To pinpoint specific residues within the b8–b9 loop mediating N-ter-
minus self-association, we consulted the recent high-resolution electron
cryomicroscopy structures of RyR1 and RyR2.5–10. In spite of slight dif-
ferences between the RyR1 and RyR2 structures and the lack of resolu-
tion for the side chain of some residues, RyR2 amino acids Q168, D179,
and D180 appear to lie at the inter-subunit interface (Supplementary ma-
terial online, Table S3). In particular, Q168 is in close proximity to the
backbone of G239 (at the edge of the b13 strand) and the negatively
charged side chain of D400 (within the b23–b24 loop). D179 and D180
are near to the positively charged side chain of H398, hydrophobic side
chain of M399 and the peptide bond between these two residues (within
the b23–b24 loop). We, therefore, generated separate NT constructs
with double alanine substitutions of residues K167 þ Q168, D179 þ
D180, and E173þ K174, the latter to serve as negative control for use in
cross-linking assays (n= 8). As expected, NTE173A þ K174A produced tet-
ramers equivalent to NTWT demonstrating the specificity of our assay.
Tetramer formation of NTK167A þ Q168A was similar to WT suggesting
that putative interactions of the polar residue Q168 are of low affinity.
On the other hand, the D179Aþ D180A mutant significantly decreased
(by 57% at 60 min) tetramer formation (Figure 2). These results validate
the data obtained with the b8–b9 loop deletion and demonstrate that
the negatively-charged residues D179/D180 are necessary for efficient
RyR2 N-terminus self-association.
4 M. Seidel et al.
D
ow
nloaded from
 https://academ
ic.oup.com
/cardiovascres/article-abstract/doi/10.1093/cvr/cvaa043/5741411 by guest on 22 April 2020
..
..
..
..
..
..
..
..
..
..
..
..
..
.
3.2 The b8–b9 loop is required for RyR2
subunit oligomerization but dispensable
for N-terminus interaction with
C-terminus
The near-atomic determination of the RyR1/2 structure revealed that
sequences within the N-terminus, including the b8–b9 loop, may form
several interfaces with sequences within the ‘core solenoid’ domain at
the C-terminus.5–10 To reveal specific b8–b9 loop involvement in the
putative N-terminus interaction with the pore-forming C-terminal re-
gion, we carried out co-IP experiments using HEK293 cells co-
expressing NTWT or NTDb8–b9 together with HA-tagged RyR2-CT (resi-
dues 3529–4967). Assays were carried out in nominally zero Ca2þ
(1 mM EGTA) or its presence (100lM CaCl2) due to potential Ca
2þ-
binding site(s) within the C-terminus that may affect the interac-
tion.5,6,8,10 HA-RyR2-CT was immunoprecipitated with AbHA, verified
by immunoblotting (Figure 3A, bottom panel), while the presence of co-
precipitated NTWT or NTDb8–b9 was analysed by western blotting using
Figure 1 Deletion of the b8–b9 loop perturbs RyR2 N-terminus tetramerization. Chemical cross-linking assays of HEK293 cell homogenates expressing
NT (RyR2 residues 1–906) WT or deletion mutants: NTDb8–b9 (residues 167–178 removed), NTb13–b14/4Ala (residues 240–243 substituted by alanine),
NTDb20–b21 (residues 335–358 removed), NTDb23–b24 (residues 399–401 removed), and NTDb31–b32 (residues 748–752 removed). (A) Cell homogenates
were incubated with glutaraldehyde for the indicated time points under reducing (10 mM DTT) conditions and analysed by western blotting using AbcMyc;
monomer (M) and tetramer (T) are indicated with the arrows. (B) Densitometry analysis (n >_ 6) was carried out on the bands corresponding to tetramer
and monomer moieties and used to calculate tetramer formation. Data are given as mean value ± SEM; statistical analysis was carried out using Kruskal–
Wallis test with Dunn’s multiple comparison test. SEM, standard error of the mean.
A ryanodine receptor domain vital for Ca2þ release 5
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the negative control with non-immune rabbit IgG, irrespective of the
presence (100lM CaCl2) or absence (1 mM EGTA) of Ca
2þ (Figure 3A).
Similarly, NTDb8–b9 was efficiently co-immunoprecipitated with HA-
RyR2-CT under both Ca2þ-free and Ca2þ-containing conditions.
Quantitative data (n= 6) indicated RyR2-CT interaction with NTDb8–b9
are comparable to that with NTWT and that this is unaffected by the
presence of Ca2þ (Figure 3B). These results indicate a Ca2þ-independent
interaction between the RyR2 N- and C-termini that does not require
the presence of the b8–b9 loop.
Given that N-terminus self-association is required for efficient
oligomerization of full-length RyR2,13 we assessed the involvement of
the b8–b9 sequence in RyR2 oligomerization by sucrose density gradient
centrifugation. RyR2WT and RyR2Db8–b9 (amino acids 167–178 re-
moved) were expressed in HEK293 cells, CHAPS-solubilized micro-
somes were separated through linear 5–40% sucrose gradient, and
gradient fractions were analysed by western blotting using Ab1093
(Figure 4). RyR2WT was predominantly found in ‘heavy’ sucrose fractions
(28%) consistent with tetramer formation. In contrast, RyR2Db8–b9
was found distributed throughout the gradient, a sedimentation profile
indicative of weakly-associated tetramers in equilibrium with dissociated
subunits.
3.3 The b8–b9 loop is required for RyR2
channel activation
RyR2Db8–b9 function was investigated within the intact cellular milieu us-
ing confocal microscopy and Ca2þ imaging to monitor spontaneous
Ca2þ oscillations.13,21 Successful RyR2 expression was verified by immu-
nofluorescence using Ab1093 indicating comparable transfection effi-
ciency for RyR2WT and RyR2Db8–b9 (Supplementary material online,
Figure S1). Cells expressing RyR2WT displayed the characteristic pattern
of repetitive Ca2þ transients and also responded to suboptimal (1 mM)
and maximal (10 mM) caffeine application (Figure 5). In contrast, cells
expressing RyR2Db8–b9 exhibited very rare and diminished Ca2þ transi-
ents. Interestingly, RyR2Db8–b9-expressing cells had a similar response to
WT when challenged with 1 mM caffeine but their response to maximal
caffeine application was restrained compared to RyR2WT. The subdued
RyR2Db8–b9 caffeine response did not allow for determination of the ER
Ca2þ content, typically taken as the amplitude of the maximal caffeine-
induced Ca2þ transient. To determine the relative ER Ca2þ content of
cells expressing RyR2WT and RyR2Db8–b9, we used the suboptimal caf-
feine dose to sensitize RyR2 (1 mM, a dose that produced comparable
response between WT and mutant) followed by (1lM) thapsigargin
Figure 3 The b8–b9 loop is dispensable for RyR2 N-terminus interaction with C-terminus. Co-immunoprecipitation assays from HEK293 cells co-
expressing NTWT or NTDb8–b9 together with HA-tagged RyR2-CT (residues 3529–4967) in the presence of 1 mM EGTA or 100 lM CaCl2 as indicated. (A)
HA-RyR2-CT was immunoprecipitated with AbHA from CHAPS-solubilized cell lysates and the presence of co-precipitated NTWT/NTDb8–b9 was analysed
by western blotting using AbcMyc (top). To detect immuno-isolated HA-RyR2-CT, one-tenth of IP samples was analysed by western blotting using AbHA
(bottom). Non-immune rabbit IgG served as negative control (non-specific binding). An aliquot of HEK293 cell lysate corresponding to 1% of the amount
processed in the co-IP assay was included in the gels to assess protein expression. (B) Data summary (n = 6) for NT-specific binding (non-immune IgG IP sig-
nal subtracted from anti-HA IP signal) following densitometry analysis and normalization to each construct’s respective lysate (taken as 100%). Data are given
as mean value ± SEM; statistical analysis was carried out using one-way analysis of variance with Bonferroni’s multiple comparisons test.
Figure 2 Aspartate 179 and aspartate 180 are indispensable for
RyR2 N-terminus tetramerization. Chemical cross-linking assays (n = 8)
of NTWT, NTK167A þ Q168A, NTE173A þ K174A, and NTD179A þ D180A as
described in the legend to Figure 1. Data are given as mean value ± SEM;
statistical analysis was carried out using Kruskal–Wallis test with Dunn’s
multiple comparison test.
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(inhibitor of the SR/ER Ca2þ ATPase pump) to empty the ER Ca2þ store,
which was measured by integration of the resultant cytosolic Ca2þ
transient. The summary of the Ca2þ imaging data presented in Figure 5B
demonstrates that the RyR2 b8–b9 loop deletion drastically alters
cellular Ca2þ cycling characteristics (Ca2þ transient amplitude, duration,
frequency, and ER Ca2þ store). First, Ca2þ transient amplitude was re-
duced compared to WT, despite higher ER Ca2þ store, which could indi-
cate that RyR2Db8–b9 is unable to open fully. Second, there was a
significant decrease in the number of spontaneous Ca2þ oscillations
compared to WT. This observation combined with the inability of caf-
feine to trigger maximum activation of the channel suggest that
RyR2Db8–b9 exhibits profoundly altered sensitivity to agonists. Third, the
ER Ca2þ store content was higher relative to WT, suggesting that
RyR2Db8–b9 is much less prone to spontaneous channel opening than
RyR2WT. Fourth, RyR2Db8–b9-expressing cells displayed a longer Ca2þ
transient due to the larger Ca2þ store. These results indicate that resi-
dues 167–178 are crucial for RyR2 Ca2þ release.
As an alternative assay to assess the caffeine response of RyR2Db8–b9,
we used high-affinity [3H]ryanodine binding of microsomal membranes.
Experiments were conducted using HEK293 microsomes expressing
equal amounts of RyR2WT or RyR2Db8–b9 verified by immunoblotting
(Supplementary material online, Figure S2) in the presence of 100lM
Ca2þ and 10 mM caffeine to promote maximum channel activation.
Despite an equal amount of RyR2 protein, the b8–b9 loop deletion
mutant displayed negligible [3H]ryanodine binding (2.0 ± 0.9 fmol/mg for
RyR2Db8–b9 vs. 30.6± 2.0 fmol/mg for RyR2WT, P< 0.01). Given that the
caffeine and ryanodine-binding sites are located within the C-terminal
transmembrane assembly,5 it is very unlikely that the small N-terminal
deletion of residues 167–178 directly affects ligand binding. On the other
hand, ryanodine (at nanomolar concentrations) binds only to intact RyR
tetramers,22 which are compromised in RyR2Db8–b9 (Figure 4). Thus, the
minute amount of bound [3H]ryanodine could only partly be due to di-
minished RyR2Db8–b9 response to agonists.
3.4 The arrhythmogenic R176Q mutation
within the b8–b9 loop reduces N-terminus
tetramerization and produces gain-of-
function channels
To examine the involvement of the b8–b9 loop in RyR2 pathophysiol-
ogy, we investigated the R176Q mutation linked with arrhythmogenic
right ventricular dysplasia type 2 (ARVD2)23 and catecholaminergic poly-
morphic ventricular tachycardia (CPVT).24 Consistent with the results
obtained with the b8–b9 loop deletion, chemical cross-linking analysis
(n= 8) of NTR176Q indicated reduced N-terminus tetramer formation
(by 58% at 60 min) compared to WT (Figure 6A), and co-IP assays (n>_ 8)
demonstrated HA-RyR2-CT binding for NTR176Q equivalent to NTWT
(Figure 6B). However, unlike RyR2Db8–b9 tetrameric channels which
were unstable, sucrose density gradient centrifugation (n= 4) of
RyR2R176Q demonstrated full-length subunit oligomerization similar to
WT (Figure 6C). These findings suggest that although the R176Q muta-
tion disrupts N-terminus self-association, it has no effect on N-terminus
interaction with C-terminus nor on RyR2 subunit oligomerization.
The functional effects of the R176Q mutation were investigated by
single-cell Ca2þ imaging to monitor spontaneous Ca2þ oscillations in in-
tact cells. In contrast to RyR2Db8–b9 that produced restrained intracellu-
lar Ca2þ mobilization, RyR2R176Q-expressing cells displayed prominent
Ca2þ oscillations (Figure 7). Compared to WT, RyR2R176Q displayed a
significant increase in the number of spontaneous Ca2þ transients with a
concomitant smaller Ca2þ store, suggesting that the R176Q mutation
results in hypersensitive and leaky channels. Ca2þ transient duration was
smaller in RyR2R176Q-expressing cells most likely because there is less
calcium available for release due to the smaller Ca2þ store.
4. Discussion
The N-terminus domain of RyR2, one of the three arrhythmia-
associated mutation hot-spots, is an important structural and functional
regulatory element involved in both activation and termination of SR
Ca2þ release.13,15,25–27 The present study significantly extends previous
findings by structurally defining the primary interaction sites mediating
N-terminus self-association and also functionally demonstrates that the
b8–b9 sequence is critically involved in RyR2 channel activity.
4.1 The b8–b9 loop is the primary
determinant for RyR2 N-terminal
inter-subunit interactions
High-resolution topological data11,12 enabled us to target discrete
domains, namely the peptide sequences connecting the b8 strand with
b9, b13 with b14, b20 with b21, and b23 with b24. We found that dele-
tion of the b8–b9 loop severely compromises RyR2 N-terminus tetra-
merization, whereas deletion of the b23–b24 sequence results in a
Figure 4 Deletion of the b8–b9 loop impairs RyR2 oligomerization.
Protein distribution profile of RyR2WT and RyR2Db8–b9 assessed by su-
crose density gradient centrifugation. (A) RyR2WT and RyR2Db8–b9
were expressed in HEK293 cells, CHAPS-solubilized microsomal mem-
branes were subjected to density-gradient centrifugation and collected
sucrose fractions were analysed by western blotting using RyR2 Ab1093.
Microsomes (25 lg, M) were also included to assess protein expres-
sion; sucrose concentration as indicated. (B) Cumulative data (n = 4)
following densitometry analysis and normalization against the amount
of input protein in the microsomes; data are given as mean value ±
SEM.
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Figure 5 RyR2Db8–b9 displays drastically altered intracellular Ca2± release dynamics. Single-cell Ca2þ imaging using confocal laser scanning microscopy to
monitor spontaneous Ca2þ release transient events. (A) Traces from Fluo-3 loaded single HEK293 cells expressing RyR2WT or RyR2Db8–b9 showing spon-
taneous Ca2þ transients and Ca2þ release induced by caffeine (1 mmol/L, 10 mmol/L) or thapsigargin (1 lmol/L). (B) Ca2þ transient characteristics, including
amplitude, duration, and frequency of events, were analysed for 84 cells expressing RyR2WT and 81 cells expressing RyR2Db8–b9 from four separate experi-
ments, whereas the caffeine response for at least 20 cells. The ER Ca2þ store content was measured by integration of the (1 lmol/L) thapsigargin-induced
Ca2þ release (following 1 mmol/L caffeine application) at the end of each experiment. Data are normalized for RyR2WT and expressed as mean value ±
SEM; statistical analysis was carried out using Mann–Whitney test.
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modest decrease (Figure 1). Conversely, deletion of the b20–b21 loop
and the four-alanine substitution within the b13–b14 loop is largely with-
out effect. These findings suggest that the b8–b9 loop is the principal
oligomerization determinant, with the b23–b24 loop having a supporting
role. Residues within the b13–b14 and b20–b21 loops do not appear to
play a prominent role in N-terminus self-association; however, we can-
not fully dismiss the contribution of these sequences due to limitations
of our experimental approach. In particular, introduced deletions may
not have been structurally disruptive due to compensatory structural
rearrangements of neighbouring residues. This kind of protein plasticity
has been previously reported in RyR2 for the disease-causative deletion
of exon 3.28 Alternatively, deletion of an individual domain may not have
been detrimental to N-terminus oligomerization due to the presence of
additional determinants. The recent near-atomic electron cryomicro-
scopy maps of RyR1 and RyR2 confirm N-terminus tetrameric arrange-
ment, which appears to be mediated through residues on a single inter-
subunit interface that is qualitatively similar between these two RyR iso-
forms.7,9 The contact interface is likely formed by residues within the
b8–b9 loop (and within the b2 sheet for RyR1 only) of subunit A, which
are in close proximity (within 5 A˚) with residues within the b13–b14 and
b23–b24 loops (as well as within the b24 sheet for RyR1 only) of subunit
B (Supplementary material online, Table S3). Using alanine substitution
mutagenesis of the b8–b9 sequence, we found that the negatively
charged RyR2 residues D179 and D180, which are closely opposed to
amino acids H398 and M399 within the b23–b24 loop, perturbed N-ter-
minus tetramerization (Figure 2). Notably, the D179N mutation has been
linked with CPVT and the equivalent RyR1 residue (D166G and D166N)
has been linked with malignant hyperthermia (Supplementary material
online, Figure S3), further highlighting the pivotal involvement of the nega-
tively charged side chain of this residue in N-terminus self-association.
Thus, our empirical data together with the structural information dem-
onstrate that the RyR2 N-terminal inter-subunit interaction is primarily
mediated by amino acids 179–180 within the b8–b9 loop interacting
with residues 398–399 within the b23–b24 loop of an adjacent subunit.
An additional finding of the present study is the demonstration of
Ca2þ-independent RyR2 N-terminus interaction with the C-terminal re-
gion encompassing the pore-forming transmembrane segments and the
preceding structural element termed ‘core solenoid’.5,7,9 We have previ-
ously shown an interaction between the isolated N-terminus and the ex-
treme C-terminal tail (residues 4867–4967) of RyR215; however, the
latter is buried within the context of the full-length protein,5–10 and
therefore, this interaction does not confer physiological relevance for
RyR2. Interestingly unlike RyR, the N-terminus and C-terminal tail of the
related inositol trisphosphate receptor calcium release channel—which
have high-peptide sequence and structural similarity with the corre-
sponding RyR domains—are closely apposed in the context of the full-
length channel, allowing for direct interaction to occur.29 In contrast, the
high-resolution RyR1/2 structures indicate extensive contacts (within
5 A˚) between the N-terminus and the core solenoid (residues 3620–
4210).5,7,9 Interestingly, several disease-causative RyR1/2 mutations re-
side at these interfaces, suggesting a pathogenic role for altered associa-
tion between N- and C-termini. Notably, the b8–b9 interface with the
core solenoid is largely unaltered in the transition from the closed to
the open state of the RyR2 channel, whereas the b8–b9 interface with
the neighbouring N-terminus domain is widened in the open compared
to the closed state7 (Supplementary material online, Table S3). The
results presented here are consistent with the structural information
and further indicate that the recently identified, C-terminal Ca2þ-binding
site5 is unlikely to affect N-terminus to C-terminus cross-talk.
Importantly, the b8–b9 loop was found to be dispensable for N-termi-
nus interaction with C-terminus (Figure 3) and, therefore, its role in
Figure 6 The pathogenic R176Q mutation decreases N-terminus
tetramerization but it has no effect on N-terminus interaction with C-
terminus or RyR2 tetramer assembly. (A) Chemical cross-linking assays
(n = 8) of NTWT and NTR176Q as described in the legend to Figure 1.
Data are given as mean value ± SEM; statistical analysis was carried out
using Mann–Whitney test. (B) Co-immunoprecipitation assays (n >_ 8)
of HA-RyR2-CT with NTWT or NTR176Q as described in the legend to
Figure 3. Data are given as mean value ± SEM; statistical analysis was car-
ried out using Student’s t-test. (C) Sucrose density gradient centrifuga-
tion (n = 4) of RyR2WT and RyR2R176Q as described in the legend to
Figure 4; data are given as mean value ± SEM.
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RyR2 channel function seems to be primarily mediated through the regu-
lation of N-terminal inter-subunit interactions.
The b8–b9 sequence is required not only for tetramerization of the
N-terminus domain but also of the full-length RyR2 (Figure 4). This ob-
servation, which is consistent with our previous findings on the arrhyth-
mogenic L433P mutation,13 highlights a crucial role for the N-terminal
domain in RyR2 subunit oligomerization. Early work has demonstrated
that the RyR C-terminal region containing the transmembrane domains
forms a tetrameric cation-conducting pore that binds ryanodine.30–32
Moreover, the extreme C-terminal tail not only forms tetramers by it-
self33 but it is also essential for RyR subunit tetramerization.34 These
studies together with the present results indicate that both the N-termi-
nus and C-terminus domains are necessary—but insufficient on their
own—for efficient RyR tetramer assembly.
4.2 The b8–b9 loop is indispensable for
RyR2 function
Notably, the b8–b9 loop is a key functional element indicated by the dys-
functional RyR2Db8–b9 mutant. We found that deletion of residues 167–
178 leads to defective channels that tend to remain inactive in living cells,
indicated by subdued spontaneous Ca2þ oscillations in terms of both
frequency and amplitude, and despite a higher ER Ca2þ content
(Figure 5). These results are not surprising though, given that RyR2Db8–b9
displays reduced tetramer assembly with dissociated subunits unable to
form Ca2þ-conducting channels. The indispensable role of the b8–b9 se-
quence in channel function is highlighted by its extreme conservation
across isoforms and species (including invertebrate RyR), as well as being
the target of numerous RyR1/2 mutations associated with skeletomuscu-
lar and cardiac disease (Supplementary material online, Figure S3).
In this study, we biochemically and functionally characterized the
arrhythmogenic R176Q mutation within the b8–b9 loop in RyR2. In
agreement with previous reports,35–37 we found that RyR2R176Q is a hy-
persensitive leaky channel displaying higher frequency of spontaneous
Ca2þ transients and smaller intracellular Ca2þ store (Figure 7). To iden-
tify the molecular/structural defect(s), we carried out chemical cross-
linking, co-immunoprecipitation, and gradient centrifugation analyses
(Figure 6). We found that the R176Q mutation has the following effects:
(i) weakens N-terminus tetramerization, (ii) has no effect on N-terminus
interaction with C-terminus, and (iii) has no effect on full-length RyR2
subunit oligomerization. These findings indicate that disruption of N-ter-
minal inter-subunit interactions is the primary mechanism underlying
gain-of-function RyR2R176Q. Consistent with our results, previous
Figure 7 RyR2R176Q displays hypersensitive channel characteristics. Single-cell Ca2þ imaging using confocal laser scanning microscopy to monitor spon-
taneous Ca2þ release transient events in HEK293 cells expressing RyR2WT or RyR2R176Q as described in the legend to Figure 5. Data from 66 cells
expressing RyR2WT and 222 cells expressing RyR2R176Q from four separate experiments, are normalized for RyR2WT and expressed as mean value ±
SEM; statistical analysis was carried out using Mann–Whitney test.
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solution nuclear magnetic resonance (NMR) and crystal structure stud-
ies showed that the R176Q mutation causes only local structural pertur-
bations within the b8–b9 sequence proposed to affect the N-terminus
inter-subunit interface.38
At first sight, our functional observations for RyR2Db8–b9 and
RyR2R176Q, namely loss-of-function and gain-of-function channel, respec-
tively, appear contradictory with each other. Both the b8–b9 deletion
and R176Q mutation disrupt N-terminus tetramerization but the effect
is more severe in the former, while neither manipulation alters N-termi-
nus interaction with C-terminus. Notably though, unlike the R176Q mu-
tation, the b8–b9 deletion also impairs full-length RyR2 subunit
oligomerization, which accounts for the loss-of-function phenotype.
Tellingly, the previously characterized L433P mutation, which also re-
duced both N-terminus tetramerization and full-length tetramer assem-
bly, displayed both gain-of-function and loss-of-function
characteristics.13 A closer look at the chemical cross-linking data (at
60 min) suggests a gradual effect in N-terminus tetramerization effi-
ciency, which is in turn linked to tetrameric channel assembly, with the
two biochemical defects having contrasting functional effects. RyR2WT
has robust N-terminus tetramerization stabilizing the closed conforma-
tion of intact tetrameric channels. Moderate disruption (by 58%) of N-
terminus tetramerization but retaining intact full-length tetramers in
RyR2R176Q, is manifested as a gain-of-function channel. Severe disruption
(by 79%) of N-terminus tetramerization resulting in impairment of full-
length tetramer assembly in RyR2Db8–b9, is manifested as loss-of-
function channel. RyR2L433P with reduced (by 67%) N-terminus tetrame-
rization and concomitant impairment of full-length tetramer assembly
lies in between the two, displaying characteristics of both hypersensitive
and hyposensitive channel.13
Our present findings implying that the b8–b9 domain is involved in
both opening and closing of the channel, are compatible with previous
reports demonstrating that the N-terminus governs both activation and
termination of SR Ca2þ release.13,15,25–27 Moreover, they have impor-
tant clinical implications. While the vast majority of RyR2 mutations pro-
duce hypersensitive channels with increased diastolic SR Ca2þ leak
resulting in delayed after-depolarizations, there is a handful of distinct
RyR2 mutations including the ARVD2-linked L433P13,37 and the hyper-
trophic cardiomyopathy-linked A1107M mutation reported to reduce
Ca2þ release.27 In addition, the CPVT-linked A4860G mutation was
found to depress RyR2 channel activity,39 whereas ventricular myocytes
from A4860G knockin mice had reduced amplitude of systolic Ca2þ re-
lease with overloaded SR Ca2þ content, which randomly caused bursts
of prolonged systolic Ca2þ release triggering early after-depolariza-
tions.40 Thus, it is conceivable that drugs that target gain-of-function
RyR2 mutations, while beneficial for the majority of patients, may have
deleterious effects on patients harbouring loss-of-function mutations.
4.3 Limitations
The present study made use of targeted removal of peptide loops con-
necting neighbouring b strands and despite being designed following
careful bioinformatics analysis of the available structural data, we cannot
exclude the possibility of local or global conformational changes. The
functional observations seen with deletion of residues 167–178 could be
due to altered global conformation of the channel—although the
remaining three residues within this loop would be expected to bridge
the b8 and b9 strands. Moreover, the deletion did not affect the
N-terminus interaction with the C-terminus arguing against global
conformational destabilization. Thus, it is likely that RyR2Db8–b9 dysfunc-
tion is due to the specific loss of one of the contact sites at the N-
terminus inter-subunit interface, which in turn perturbs the assembly of
functional tetrameric channels.
The present work employed RyR2-expressing HEK293 cells because
the study of genetically manipulated RyR2 is not feasible in the native
context unless animal knockin models are available. At present, there is
no efficient methodology to deliver the very large (15 kb) RyR2 cDNA
inside cardiac myocytes, whereas gene editing is generally believed to be
feasible only for actively dividing cells. A recent study has indicated that
homology-directed repair is feasible in non-dividing cardiac myocytes in
culture; however, gene editing was of low efficiency (up to 20–25%) for
cardiac myocytes at neonatal stage, and it was not observed in adult
cells.41 The RyR2-expressing HEK293 system is an experimental cellular
assay that recapitulates spontaneous Ca2þ release under Ca2þ overload
conditions in cardiac myocytes.20,42 Enhancement of RyR2 activity with
caffeine43,44 or CPVT gain-of-function mutations (e.g. R4496C)20,45,46 re-
sult in higher frequency of spontaneous Ca2þ transients and lower Ca2þ
store content in both HEK293/RyR2 cells and cardiac myocytes. One
discrepancy is that Ca2þ transient amplitude is largely unaffected in
HEK293/RyR2 cells, whereas it is decreased in cardiac myocytes impli-
cating the involvement of cardiac-specific accessory proteins.
5. Summary
We identify a short peptide sequence, which, although located remotely
from the pore in terms of both primary and tertiary structure, is vital for
RyR2 channel gating. The empirical findings presented in this study to-
gether with the known structural information allow us to draw a plausi-
ble hierarchical order of events leading to RyR2 channel activation.
Efficient inter-subunit N-terminus to N-terminus communication medi-
ated by the b8–b9 loop is likely to constitute a primary signal for RyR2
gating. This may then be transmitted in a Ca2þ-insensitive manner to the
core solenoid domain via N-terminal sequences other than the b8–b9
residues, and subsequently conveyed on to the C-terminal channel do-
main to induce gating of the pore. Perturbation of N-terminal inter-
subunit interactions, solely or in combination with impairment of RyR2
tetramer assembly, can lead to either gain-of-function or loss-of-function
channels, respectively.
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Translational perspective
Our findings that the ryanodine receptor 2 (RyR2) b8–b9 loop is involved in both Ca2þ release channel opening and closing have important clinical
implications. This RyR2 domain is a known ‘hot-spot’ for mutations associated with arrhythmogenic cardiac disease, which could produce hypersen-
sitive and hyposensitive channels. Therapeutic strategies currently focus on gain-of-function RyR2 channels to suppress sarcoplasmic reticulum
Ca2þ release either indirectly with Class I/II anti-arrhythmic drugs, or by directly targeting RyR2 to inhibit channel activity. These strategies may not
only be ineffective but also they may exacerbate the malignant phenotype in the case of loss-of-function RyR2 mutations.
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